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Distinct Roles of the Phosphatidylinositol
3-Kinase and STAT5 Pathways in IL-7-Mediated
Development of Human Thymocyte Precursors
The signals that couple IL-7 to its effect on survival
proliferation and differentiation of T cell precursors are
yet poorly defined. The receptor for IL-7 (IL-7R) is com-
posed of the IL-7-specific chain (IL-7Ra) and the com-
mon g chain (gc), shared by the IL-2, IL-4, IL-9, and IL-
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15 receptors (Noguchi et al., 1993b). Binding of IL-7 toAntoni van Leeuwenhoekhuis
IL-7R results in activation of tyrosine kinases from thePlesmanlaan 121
Janus family, JAK1 and JAK3, which are preassociated1066 CX Amsterdam
with the IL-7Ra and the gc, respectively (Johnston etThe Netherlands
al., 1994; Miyazaki et al., 1994; Russell et al., 1995). The²Department of Oncology
JAK kinases phosphorylate tyrosine residues of severalUniversity of Cambridge
substrates, among them the cytoplasmic domain of theSchool of Clinical Medicine
IL-7R. While the essential role of JAK1 (Rodig et al.,Medical Research Council Laboratory
1998), and JAK3 (Macchi et al., 1995; Nosaka et al.,of Molecular Biology
1995) in IL-7-mediated T cell development is now estab-Cambridge CB2 2XY
lished, it is unknown yet which signaling molecules cou-United Kingdom
ple these kinases to the T cell developmental program.
In murine B cells, the lipid kinase phosphatidylinositol-3
kinase (PI-3K) has been shown to be activated afterSummary
being recruited by the Y449 residue of the IL-7Ra chain
(Venkitaraman and Cowling, 1994; Corcoran et al., 1996).Here, we define the IL-7R-activated signal that pro-
PI-3K is composed of an 85 kDa regulatory subunit andmotes survival and proliferation of T cell progenitors
a 110 kDa catalytic subunit. The P85 component associ-and demonstrate that it is distinct from the signals that
ates with receptors and is tyrosine phosphorylated in ainduce differentiation. We show that IL-7 activates PKB
ligand-dependent fashion by many growth factors andand STAT5 in human thymocytes. Into T cell precur-
cytokines (Kapeller and Cantley, 1994), suggesting ansors we introduced chimeric receptors with a cyto-
involvement of PI-3K in growth regulation. Indeed, theplasmic domain of the IL-7R that is no longer able to
IL-7-induced PI-3K activity was shown to be necessaryactivate PI-3K/PKB and STAT5 and tested the trans-
to induce proliferation of pre-B cells (Corcoran et al.,duced cells in a fetal thymic organ culture. We also
1996). However, whether PI-3K is involved in T cell devel-examined the T cell precursor activity of progeni-
opment has not been investigated. One of the most likelytors expressing dominant-negative forms of PI-3K or
downstream cellular effectors of PI-3K is protein kinaseSTAT5B. These experiments revealed that PI-3K/PKB
B (PKB), which seems to play a central role in PI-3K-
activation is essential for the survival and proliferation
mediated protection against apoptosis (Burgering and
of T cell precursors and suggest that STAT5 activated Coffer, 1995). PKB has been shown to be downstream
by IL-7 mediates T cell differentiation. of PI-3K in IL-2 signaling (Brennan et al., 1997), but its
role in Il-7 signaling is unknown.
Interaction of IL-7 with the IL-7Ra chains results inIntroduction
activation of STAT5. In human PBMC, the Y449 residue
of the IL-7Ra chain has been implicated in recruitment
Interleukin (IL)-7 plays a key role in the development of
of STAT5 (Lin et al., 1995). It is unclear whether STAT5
T cells both in mouse and human. Mice deficient for IL-7
is involved in T cell development. Mice deficient for
(Von Freeden-Jeffry et al., 1995) or one of the compo- both STAT5A and STAT5B have no major decrease in
nents of its receptor (Peschon et al., 1994; DiSanto et thymocyte number (Teglund et al., 1998). More recently,
al., 1995) demonstrate a strongly impaired T cell devel- however, it was observed that STAT5B-deficient mice
opment. Defects in the IL-7 receptor a (Puel et al., 1998) have a reduced cellularity of the thymus (Imada et al.,
or g chains (gc) (Noguchi et al., 1993a) in human result in 1998). This observation raises the possibility that part
a severe combined immunodeficiency syndrome (SCID) of the effect of IL-7 on T cell development might be
characterized by a complete lack of T cells. An important mediated through STAT5B.
function of IL-7 appears to be the promotion of survival Here, we document that IL-7 activates PKB and STAT5
and proliferation of immature thymocytes (Akashi et al., in human thymocytes. The biological roles of the PI-3K/
1997; Maraskovsky et al., 1997; von Freeden-Jeffry et PKB and STAT5 pathways in early human T cell develop-
al., 1997). In addition to its survival-promoting effect on ment were studied by testing in a fetal thymic organ
developing TCRgd cells, IL-7 can have a direct differenti- culture (FTOC) human thymic progenitors overexpress-
ation-promoting effect on TCRgd cells (Maki et al., 1996) ing IL-7 chimeric receptors that are no longer able to
by controlling accessibility of the TCRg locus (Durum et activate the PI-3K/PKB or the STAT5 pathway. We also
al., 1998). tested progenitor cells expressing dominant-negative
forms of either PI-3K and STAT5B in an FTOC. These
experiments together demonstrate that both pathways³ To whom correspondence should be addressed (e-mail: hergen@
nki.nl). are involved in T cell development. PI-3K plays a crucial
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Figure 1. Anti-IL-7Ra Chain Antibodies In-
hibit T but Not NK Cell Development in an
FTOC
CD341 cells were isolated and incubated in
FTOC either in the presence of an isotype-
matched control antibody (A) or anti-IL-7Ra
antibody (B). Cell suspensions were stained
with the indicated TriColor (y axis)- and PE-
labeled (x axis) antibodies and analyzed on a
FACScan.
role in mediating a proliferative and/or a survival signal Addition of IL-4 to an FTOC with Thymic Progenitors
Expressing a Chimeric IL-4/IL-7 Receptorin human thymocytes, thereby contributing to the ho-
Overcomes the Blocking Effectmeostasis of thymocyte precursors. Our results further-
of Anti-IL-7Ra Antibodymore indicate that STAT5 isoforms are required for regu-
On the basis of the results presented in Figure 1, welation of differentiation.
have set up a system that allows us to find the domains
in the IL-7Ra chain critical for T cell development. Chi-
meric IL-4/IL-7 receptors are introduced into CD341 thy-Results
mic precursors followed by incubation of the transduced
cells in an FTOC in the presence of anti-IL-7Ra. ByInhibition of the IL-7R Signaling by Anti-IL-7Ra
triggering the expressed chimeric chain with hIL-4, weAntibodies Blocks T Cell Development
expected to restore T cell development of the cells ex-in an FTOC
pressing the chimeric IL-4R/IL-7R. Before testing theRecently, it was reported that addition of anti-IL-7 or
feasibility of this system, we ascertained that thymic
anti-IL-7Ra antibodies inhibits development of CD31 T progenitors lacked expression of IL-4R and that hIL-4
cells in an FTOC (Plum et al., 1996). The relative contribu- did not affect T cell development of CD341 cells (data
tion of IL-7 to development of TCRab and gd T cells not shown).
was not evaluated in that study. Moreover, the effect of We transduced CD341 cells with a vector harboring
anti-IL-7Ra on NK development in the FTOC was not the chimeric receptor or with a control vector containing
examined. CD341 thymocytes were purified and incu- GFP only (C-GFP). The control-transduced cells were
bated in an FTOC with and without anti-IL-7Ra. The anti- incubated in an FTOC without anti-IL-7Ra antibody to
IL-7Ra antibody strongly blocked ab T cell development examine the effect of the transduction procedure on T
cell development in our system. A total of 130,000 cellsas indicated by the dramatic decrease of the percent-
were divided over six thymic lobes. At day 0 at the onsetages of CD41, CD41CD81, CD31, and ab1 cells (Figure
of the FTOC (2 days after infection), 15% of the cells1). Almost 90% of the cells were CD42CD82, whereas
in both IL-4R/IL-7R- and C-GFP-transduced samplesin the control FTOC, only 7% of the cells were still in that
expressed GFP giving an input number of GFP1 cells inimmature stage. These data confirmed that in human the
both samples of 20,000 cells. After 24 days of incubationIL-7Ra chain is critical for development of ab T cells
in an FTOC, 1.35 3 106 cells were recovered in the C-GFPconsistent with observations of Plum et al. (1996). Devel-
FTOC of which 15% (200,000 cells) expressed GFP; thus,opment of gd T cells was also affected by blocking the
both the untransduced and the C-GFP-transduced cellsIL-7R (Figure 1), but the level of inhibition seems to be
expanded 10-fold. We recovered 200,000 cells from the
much smaller than that of TCRab1 cells. The percentage IL-4/IL-7R FTOC, and 80% (160,000) of the cells were
of CD561CD32 NK cells increased from 3.5% in the GFP1. The untransduced cells in the IL-4/IL-7R FTOC
control versus 16.7% in the presence of anti-IL-7Ra, decreased from an input of 110,000 to an output of
possibly caused by the strong decrease of T cells in 40,000 cells as a result of inhibition by the anti-IL-7Ra
these cultures. This observation indicates that NK devel- antibody. Thus, the total expansion of GFP1 cells in both
opment is hardly if at all affected by inhibition of the cultures was similar (6 10- and 8-fold, respectively),
IL-7Ra chain, consistent with the notion that IL-7Ra indicating that triggering the chimeric IL-4R/IL-7R by
deficiency in mouse (He and Malek, 1996) and human IL-4 while blocking the endogenous IL-7R allowed re-
constitution of cell expansion.(Puel et al., 1998) does not affect homeostasis of NK cells.
Signaling of the IL-7R in T Cell Development
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Figure 2. Quantification of GFP1 Subpopula-
tions Recovered from FTOC Incubated with
CD341 Thymocytes Transduced with C-GFP
or with an IL-4/IL-7 Chimeric Receptor
CD341 cells were isolated, transduced with
viruses harboring IRES-GFP (C-GFP) or
WTIL-4/IL-7Ra-IRES-GFP (WTIL-4/IL-7Ra),
and incubated in an FTOC at 3 3 104 cells/
lobe for 24 days in the presence of antibody
against the IL-7Ra chain (50 mg/ml once a
week) and hIL-4 (30 ng/ml twice a week). (A)
Phenotype of the cells. Cell suspensions were
stained with the indicated TriColor- and PE-
labeled antibodies and analyzed on a FAC-
Scan. The input number of GFP1 cells was
20,000 for both the C-GFP and the WT recep-
tor-transduced cells both divided over six
thymic lobes. (B) Output numbers of cells of
various subsets. The numbers of GFP1 cells
(y axis) within each subpopulation (CD42
CD82 [white bars], CD41 [light gray bars],
CD41CD81 [dark gray bars], gd1 [black
bars], ab1 [indicated by a line], and NK or
CD561CD32 [striped bars]) were calculated
on the basis of the percentage of each sub-
population. A representative of four similar
experiments is shown.
Analysis of the phenotype of these GFP1 cells har- signaling via the IL-7Ra chain is needed to allow T cell
development to occur. However, the reconstitution ofvested from the FTOC revealed that IL-4 partly rescued
ab T cell development in the IL-4R/IL-7R FTOC with the development of the receptor-transduced cells by IL-4
is far from complete, as indicated by the lower numberblocking antibody (Figure 2). The percentages of CD41
and CD41CD81 cells were five times higher in the pres- of DP and the higher number of DN cells than in the
C-GFP cultures. One possible explanation for the ineffi-ence of hIL-4 than without hIL-4. However, the percent-
ages of CD41CD81 and of CD31 cells with hIL-4 were cient reconstitution of T cell development by IL-4 in our
system is that IL-7 produced by stromal cells in direct50% of those in C-GFP FTOC (Figure 2A). In terms of
cell numbers, the delay in T cell development in the IL- contact with the developing T cells provides for a much
more efficient signal than when the cytokine is supplied4R/IL-7R FTOC in the presence of anti-IL-7R1IL-4 was
more obvious (Figure 2B). The number of immature exogenously.
The percentage of CD561CD32 NK cells was de-CD42CD82 cells was almost six times higher in the IL-
4R/IL-7R FTOC in the presence of anti-IL-7R1IL-4 than creased in the FTOC with IL-4 compared to the FTOC
with the blocking antibody without IL-4 (Figure 2A). How-in C-GFP FTOC, and the number of CD41 immature
single-positive (ISP) cells was similar, whereas that of ever, the number of NK cells in the IL-4R/IL-7R FTOC
in the presence of anti-IL-7R1IL-4 was four times higherCD41CD81 was almost seven times lower than in the
C-GFP FTOC. As expected, the percentages and the than in C-GFP FTOC (Figure 2B). This increase in the
number of NK cells could be due to an artifact in ourcell numbers of ab1 and gd1 cells were increased com-
pared to the IL-7Ra-blocked FTOC without IL-4 but were system, reflecting the constitutive expression of the IL-
7Ra. We have observed that under physiological condi-not as high as in the C-GFP FTOC (Figure 2). To ensure
that the IL-7Ra tail was needed to rescue the T cell tions the IL-7Ra expression is downregulated upon mat-
uration of NK cells (data not shown). Further expansionblock observed, FTOC were performed with precursors
expressing a truncated form of the chimeric receptor of these NK cells is therefore independent of IL-7. As a
consequence of constitutive expression of the IL-4R/IL-containing only five amino acids of the intracellular do-
main of the IL-7Ra chain. As expected, IL-4 failed to 7R chimeric receptor, mature NK cells that have down-
regulated the endogenous IL-7R may further expandrescue T cell development of progenitor cells with the
truncated chimeric receptor in the presence of the block- with IL-4. This may also be the reason for the much
higher number of DN cells in the cultures with the WTing antibody (Figure 2B). Our data indicate that direct
Immunity
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Figure 3. Y449 of the IL-7Ra Chain Mediates
the Survival and/or Proliferation of Immature
CD341 Thymocyte Precursors in an FTOC
The number of GFP1 cells given for each sub-
population (CD42CD82 [white bars], CD41
[light gray bars], CD41CD81 [dark gray bars],
gd1 [black bars], ab1 [indicated by a line], and
NK or CD561CD32 [striped bars]) recovered
after 18 days are indicated. The input num-
bers were 18,500 for the WT and 37,000 for
the Y449F mutant. Because the input number
of the mutant was two times higher we di-
vided the output number by two to allow com-
parison with the WT. Similar results were ob-
tained in two repeat experiments. The right
part of the figure shows an expanded scale
of the data in the left panel.
chimeric receptor. Some of those cells may not be T mutant-transduced cells, the number of NK CD561CD32
cells was 35-fold lower compared to WT FTOC (Figurecell precursors at all but survive and proliferate because
of interaction of IL-4 with the constitutively expressed 3), indicating that the proliferative and/or survival capac-
ities conferred to NK cells by the transduced IL-4/IL-7RIL-4/IL-7R.
are mediated by the tyrosine 449. As discussed above,
the increase of NK cells generated by IL-4/IL-7R-trans-Y449 of the IL-7Ra Delivers a Proliferative
and/or Survival Signal during Early duced precursors following addition of IL-4 in the FTOC
is most likely an artifact of the system.Human T Cell Development
Since residue Y449 in the cytoplasmic chain of the IL-
7Ra chain has been shown to be a docking site for PI-
3K in B cells (Corcoran et al., 1996) and for STAT5 in IL-7 Activates PKB and STAT5
in Human Thymocyteshuman PBMC (Lin et al., 1995), we examined whether
Y449 is involved in T cell development. We prepared In view of our observation that Y449 is critical for prolifer-
ation and/or survival of early T cell precursors, it wasretroviral constructs harboring chimeric receptors con-
taining the extracellular domain of the human IL-4 recep- important to examine which signaling pathways are acti-
vated by IL-7 in thymocytes. Based on the observationstor (hIL-4R) and the transmembrane and intracellular
domains of either the wild-type hIL-7Ra chain or a mu- that IL-7 activates PI-3K in murine B cells and STAT5
in human PBMC through the Y449 residue in the IL-7Ratated form of this chain where tyrosine at position 449
was replaced by a phenylalanine. FTOC were performed chain, we investigated activation of these pathways in
thymocytes and T cells. We were also interested to knowwith CD341 thymocytes transduced with either the wild-
type IL-4R/IL-7R (WT) or the Y449F mutant (Y449F) con- whether IL-7 activates PKB, which is a potential target
of PI-3K (Burgering and Coffer, 1995). We incubatedstruct in the presence of hIL-4 and the blocking anti-IL-
7R antibody (these cultures are denoted WT FTOC and total thymocytes and the CD341 thymic subset with IL-7.
Similar results were obtained with both populations. TheY449F FTOC). At the start of the FTOC, the percentage
of Y449F-transduced cells was two times higher than cell populations were induced with IL-7 as described in
the Experimental Procedures, and total cellular extractsof WT-transduced cells due to a higher virus titer. After
18 days in an FTOC, the number of GFP1 cells had were resolved on PAGE and analyzed for the presence
of tyrosine-phosphorylated STAT5 and serine-phosphory-decreased 14 times in Y449F FTOC compared to WT
FTOC (Figure 3). Triggering the Y449F receptor did not lated PKB. In human thymocytes, IL-7 induced rapid
tyrosine phosphorylation of STAT5 (Figure 4). To deter-allow the cells to proliferate and/or to survive more than
14±18 days in an FTOC. CD41 ISP and CD41CD81 cells mine whether activation of STAT5 by IL-7 is specific,
we also analyzed the effect of stem cell factor (SCF). SCFcould still be found in the Y449F FTOC. After 18 days,
TCRab or gd cells were hardly detectable in both the collaborates with IL-7 in promoting T cell development
(Rodewald et al., 1997). It is shown in Figure 4 that SCFWT FTOC and Y449F FTOC. These T cells became de-
tectable in the WT FTOC after 24 days. However, after fails to activate STAT5, indicating the specificity of the
IL-7-mediated activation of STAT5. To analyze the effects24 days no cells could be recovered anymore from the
Y449F FTOC, precluding analysis of the Y449F mutation of IL-7 and SCF on PKB, the same blot was stripped
and hybridized with an antibody directed against phos-on generation of mature T cells.
In WT FTOC incubated for 24 days, we already found phoPKB. As expected, both IL-7 and SCF activated PKB
in human thymocytes (Figure 4). Note that phosphoPKBthat NK cell development was deregulated (Figure 2).
This effect is more striking after a shorter incubation in blot of both IL-7 and SCF-induced samples had similar
intensities, indicating that the failure to detect activatedan FTOC (Figure 3). However, in the FTOC with the Y449F
Signaling of the IL-7R in T Cell Development
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Y449F cells were analyzed by electrophoretic mobility
shift assay using a specific STAT binding site (Figure
5C). In the three cell types, two hIL-2-induced com-
plexes were detected (Figure 5D, lanes 2, 5, and 8).
These two bands contained transcription factors highly
related to both STAT5A and STAT5B, since they could
be supershifted by specific antibodies directed against
either STAT5A or STAT5B (Figure 5D, lanes 5 and 6). As
expected, hIL-4 induced the activation of STATs only in
the WT cells (Figure 5D, lanes 3, 6, and 9), which could
be supershifted by antibodies specific for STAT5A and
STAT5B (Figure 5D, lanes 10 and 11). These two hIL-2-
and hIL-4-induced STAT5-containing complexes are
similar to those described in IL-7-activated pre-B cells
and could represent dimers and tetramers of STAT5 as
suggested for the B cells (Lai et al., 1995). Alternatively,
these bands could represent various STAT5 isoforms
expressed by CTLL2 cells (Wang et al., 1996; Azam et al.,
1997). These data indicate that Y449 in the cytoplasmic
domain of the IL-7Ra is a docking site for STAT5, con-
firming the conclusions of Lin et al. (1995).
Figure 4. IL-7 Induces the Activation of Both PKB and STAT5 The PI-3K/PKB Pathway Is Involved
Partially purified CD341 postnatal thymocytes (2 3 106 cells) were in T Cell Development
incubated with no factor (2) (lane 1) or IL-7 (lane 2) or SCF (lane 3) To elucidate whether the Y449-mediated proliferation/(50 ng/ml) for 10 min at 378C, and total Triton X100 cell lysates were
survival effect on thymocyte precursors utilized the PI-analyzed by PAGE and Western blotting using a polyclonal antibody
3K/PKB pathway, we analyzed an FTOC incubated withraised against phosphoSTAT5 (top). The blot was stripped and fur-
ther incubated with a polyclonal antibody against phosphoPKB CD341 thymocytes expressing either a control GFP con-
(bottom). struct (C-GFP) or a dominant-negative form of the PI-
3K (DNP85) (Ogihara et al., 1997). The transduction effi-
ciency with the DNP85 construct at the initiation of the
FTOC was low (3%) compared to the control (10%). ThisSTAT5 in the SCF-induced samples is not due to insuffi-
is not due to differences in virus titers or toxicity ofcient protein loading.
DNP85, since NIH3T3 cells stably expressing DNP85Having demonstrated that IL-7 activates PKB and
survived and proliferated to the same extent as C-GFP-STAT5 in thymocytes, we examined whether these ef-
transduced cells (data not shown). It is therefore mostfects are mediated through the Y449 residue of the IL-
likely that enforced expression of DNP85 leads to dimin-7Ra chain. We chose to use a T cell line rather than
ished proliferation and/or survival of thymocyte precur-freshly isolated thymocyte subsets to investigate this
sors already in a very early stage. As shown in Figure 6A,point, because transduced cell lines can be manipulated
the GFP1 cell number is six times reduced in thymocytesin such a way that enough material can be obtained for
expressing DNP85 after 18 days in an FTOC comparedbiochemical analysis. We introduced the wild-type (WT)
to the C-GFP conditions. Both TCRab and gd T cellsand the mutated (Y449F) chimeric receptors in the mu-
could be detected in the cultures with DNP85 (Figurerine IL-2-dependent T cell line CTLL2 (WT, Y449F). As a
6B). While the absolute numbers of CD41CD81 cells andcontrol, we included a retroviral vector containing IRES-
more mature T cells were much lower, the percentagesGFP only (C-GFP). GFP-positive populations were sorted
of these cells in the DNP85 and the control culturesand subcloned. As shown in Figure 5A (left panel),
were comparable, indicating that DNP85 does not inhibitC-GFP, WT, and Y449F cells proliferated in response to
T cell differentiation.hIL-2 to the same extent, whereas only WT cells were
able to proliferate in response to hIL-4.
To check whether Y449 was essential for PI-3K/PKB A Dominant-Negative STAT5B Mutant Disrupts
T Cell Developmentactivation, cellular lysates from nonstimulated, hIL-2-,
or hIL-4-stimulated C-GFP, WT, or Y449F cells were DNP85 inhibited survival/proliferation of early T cell pro-
genitors, indicating that at least part of the effect of IL-7resolved by PAGE, and the presence of activated PKB
was detected by performing a phosphoPKB immunoblot on T cell development is mediated via the PI-3K/PKB
pathway. However, the inhibiting effect of the anti-IL-(Figure 5B). In all three cell types, hIL-2 induced a weak
activation of PKB (Figure 5B, lanes 2, 5, and 8) as already 7Ra antibody is stronger than that of DNP85. While this
may be caused by an incomplete inhibition of endogenousdescribed (Ahmed et al., 1997; Reif et al., 1997), whereas
PKB activation could be detected in response to hIL-4 PI-3K by the DNP85 mutant, it is also possible that STAT5
isoforms are involved in IL-7R-mediated T cell differenti-stimulation only in the WT cells (Figure 5B, lanes 3, 6,
and 9). ation. To address this point, we used a DNSTAT5B mu-
tant that possesses the wild-type SH2 domain butTo determine whether STAT5 was activated via the
IL-7Ra Y449 residue in T cells, nuclear extracts from lacked the transactivating domain. This mutant was
shown to inhibit transcriptional activation by wild-typeunstimulated, hIL-2-, or hIL-4-stimulated C-GFP, WT, or
Immunity
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Figure 5. Residue Y449 of the IL-7Ra Chain Is Crucial for Proliferation and Mediates the Activation of STAT5 and PKB in CTLL-2 Cells
(A) C-GFP, WT, or Y449F CTLL2 cells (5 3 103/point) were incubated with the indicated concentration of either hIL-2 (left) or hIL-4 (right) (ng/
ml) for 3 days, and (3H)thymidine was added for the next 8 hr.
(B) C-GFP, WT, or Y449F CTLL2 cells (2 3 106/point) were incubated with no factor (-) (lanes 1, 4, and 7) or hIL-2 (5000 IU/ml, lanes 2, 5, and
8) or hIL-4 (50 ng/ml, lanes 3, 6, and 9) for 10 min at 378C, and total cellular lysates were analyzed by PAGE and Western blotting using a
polyclonal antibody raised against phosphoPKB. Molecular weight markers are indicated on the left side (kDa).
(C) Nuclear extracts from WT CTLL2 cells (5 3 105/point) treated either with no factor (lane 1), hIL-2 (5000 IU/ml, lanes 2±6), or hIL-4 (50 ng/
ml, lanes 7±11) for 10 min were analyzed by EMSA in the absence (-) or presence of the indicated antibodies. S1, S3, S5A, and S5B are
abbreviations for antibodies against STAT1, STAT3, STAT5A, and STAT5B, respectively. ss indicates the supershifted complexes, and arrows
indicate the two STAT5-containing complexes.
(D) C-GFP, WT, or Y449F CTLL2 cells (2 3 106/point) were incubated with no factor (-) (lanes 1, 4, 7) or hIL-2 (5000 IU/ml, lanes 2, 5, and 8)
or hIL-4 (50 ng/ml, lanes 3, 6, and 9) for 10 min at 378C, and total cellular Triton lysates were analyzed by PAGE and Western blotting using
a polyclonal antibody raised against phosphoPKB. Molecular weight markers are indicated on the left side (kDa).
STAT5 (Moriggl et al., 1996). CD341 thymocytes were To confirm this point, we analyzed the effects of
DNSTAT5B overexpression in purified CD341CD1a2transduced with DNSTAT5B or GFP and incubated in
an FTOC. A total of 2 3 105 cells were introduced into thymocytes, which constitute the earliest thymocyte
precursors. In the experiment depicted in Figure 7B,seven lobes corresponding to an input of 37,000 GFP1
cells in the control and 24,000 GFP1 cells in the 2.8 3 105 transduced cells with 20% (GFP control) and
10% (DNSTAT5B) GFP1 cells, respectively, were incu-DNSTAT5B sample. Following 21 days of incubation, we
harvested 1.6 3 106 in the control, and 18% of these bated with seven lobes each. After 21 days, we recov-
ered 2 3 106 cells from the control (16% GFP1) and 106cells expressed GFP (output 2.9 3 105 cells), whereas
3.7 3 106 cells with 23% GFP1 cells were harvested cells from the DNSTAT5B (40% GFP1) cultures, respec-
tively. The calculated expansion rates were 5.6- and 14-from the cultures with DNSTAT5B cultures (output 8.5 3
105). The expansion of the DNSTAT5B-GFP1 cells (353) fold for the control and DNSTAT5B, respectively. This
result confirms that enforced expression of DNSTAT5Bis more than 4-fold higher than that of the control (7.83),
indicating that DNSTAT5B confers a growth advantage confers a growth advantage to the cells developing in
the FTOC. DNSTAT5B increased the percentage ofto cells developing in the FTOC, the opposite of what
we observed with DNP85. The percentage of CD41CD81 CD1a2CD51 cells and CD42CD82 cells and decreased
the percentages of DP cells. Few TCRab1 cells (3%)cells was decreased and that of the CD42CD82 cells
increased in the cultures with DNSTAT5B compared to were present in the DNSTAT5B sample while 12% could
be detected in the control. The percentage of TCRgd1the control (Figure 7A). Strikingly, the ratio of TCRab to
gd cells is changed in the cultures with DNSTAT5B (0.5) cells did not differ from the control but since the expan-
sion of GFP1 cells in the DNSTAT5B cultures was highercompared to the control (6). DNSTAT5B increased the
percentage of immature CD12CD51 cells (21%) com- than in the control cultures, more TCRgd1 cells were
generated in the DNSTAT5B cultures. Unexpectedly,pared to the control (4%) (Figure 7A [the phenotype of
the GFP1 cells in the control is not shown but was similar overexpression of DNSTAT5B resulted in an increase of
the percentage of CD32CD561 NK cells (27% versusto that of the untransduced cells]).
The transition of CD341CD1a2CD51 into CD341CD1a1 2% in the control) and in a much higher absolute number
of NK cells.CD51 cells is an early step in human T cell development
during which TCRg and b gene rearrangements are initi- To ensure that at least some of the effects of DNSTAT5B
are based on disruption of STAT5 activation by IL-7,ated (Blom et al., 1999). The results shown in Figure 7A
suggested that this transition is inhibited by DNSTAT5B. we examined the effect of DNSTAT5B on cultures of
Signaling of the IL-7R in T Cell Development
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Figure 6. PI-3K Activation Is Needed to Main-
tain Thymocyte Precursor Homeostasis
CD341 thymocytes were isolated and trans-
duced with IRES-GFP or DNP85-IRES-GFP
and incubated in an FTOC for 18 days.
(A) Output numbers of various subsets after
18 days in an FTOC. The number of GFP1
cells (y axis) is given for each subpopulation
(CD42CD82 [white bars], CD41 [light gray
bars], CD41CD81 [dark gray bars], TCRgd1
[black bars], TCRab1 [indicated by a line],
and NK or CD561CD32 [striped bars]). The
actual output numbers for the DN mutant
were multiplied by three to correct for the
3-fold lower input numbers of GFP1 cells
compared to the C-GFP control.
(B) Phenotype of cells harvested from FTOC
seeded with control-transduced or DNP85-
transduced CD341 thymocytes. The experi-
ment was repeated once with identical results.
CD341CD1a2 cells in IL-7. In this culture system, some and in CD341 thymocytes and that the Y449 mutation
strongly affects T cell development in our chimeric re-of the early events of T cell differentiation can be recapit-
ulated (Hori et al., 1991; MaÂ rquez et al., 1995). This differ- ceptor system support the notion that also in thymo-
cytes STAT5 and PI-3K are coupled to this residue. Con-entiation is far from complete as CD3 is not upregulated.
Figure 7C shows that DNSTAT5B also affects develop- sistent with this, dominant-negative mutants of the P85
chain of PI-3K and STAT5B disrupt development of Tment in this system, as generation of CD1a1 and
CD41CD81 cells was strongly blocked by the mutant. cells. On the basis of the observation that DNP85 inhibits
T cell development combined with the activation of PKBThese findings suggest that the effect of DNSTAT5B on
early events in T cell development in our FTOC system by IL-7 it seems fair to hypothesize that PKB links PI-
3K to its effect on T cell development. It should be noted,is based on disruption of STAT5 activation by IL-7 but
do not exclude that there are other receptors that are however, that analysis of the effect of DNPKB on T cell
development is needed to verify this.involved in T cell development through activation of
STAT5. The IL-7-induced PI-3K/PKB pathway is most proba-
bly critical for proliferation and/or survival of human
thymocyte precursors. However, it is most likely notDiscussion
involved in T cell differentiation as CD4 ISP, DP, and
mature TCRab and gd T cells could be generated whenHere, we show that the Y449 residue in the IL-7Ra chain
is critically involved in development of human T cells. the PI-3K/PKB pathway was disrupted. These results
are consistent with those obtained in B cells where theThis residue couples the receptor to two downstream
pathways, PI-3K/PKB and STAT5. This was directly IL-7-induced activation of PI-3K was shown to be crucial
for proliferation and/or survival of B cell precursors (Cor-shown with the CTLL2 cell line. The observations that
IL-7 activates both the STAT5 and the PI-3K pathways coran et al., 1996). The PI-3K pathway, already shown
to be involved in IL-2- and IL-3-induced survival andin total thymocytes (this paper; Dadi and Roifman, 1993)
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Figure 7. A Dominant-Negative STAT5B Mu-
tant Disrupts T Cell Development in an FTOC
Total CD341 cells (A) or CD341CD1a2 cells
(B and C) were purified and transduced either
with DNSTAT5B or with control-GFP. Follow-
ing incubation in an FTOC, single cell suspen-
sions were prepared and stained with the in-
dicated PE- and TRC-labeled antibodies. The
phenotypes of the GFP1 cells in the control-
transduced samples were similar to those of
the untransduced samples and are not shown.
Similar results were obtained in two other ex-
periments. (C) Phenotype of the DNSTAT5B-
transduced and untransduced CD341CD1a2
cells cultured for 9 days in a combination of
IL-7 and SCF. The percentage of GFP1 cells
in this sample was 8%.
proliferation (Brennan et al., 1997; Del Peso et al., 1997; a stronger inhibition than DNP85, although it must be
noted that a comparison of chimeric receptor-trans-Songyang et al., 1997), appears therefore to be a con-
served regulator of the balance between mitogenesis duced cultures with DNP85 and DNSTAT5 cultures is
hampered by the fact that the development of chimericand apoptosis in various cell types. It is possible that
the PI-3K pathway is instrumental in upregulation of the receptor-transduced cells is far from complete. The re-
sults of experiments with DNSTAT5 indicate that alsoapoptosis-protecting gene Bcl-2 as it has been shown
that expression of a Bcl-2 transgene in IL-7R-deficient the STAT5 pathway is involved in T cell development
and may be partly responsible for the effects of IL-7mice partly restores thymus cellularity (Akashi et al.,
1997; Kondo et al., 1997; Maraskovsky et al., 1997). The on T cell development. The effects of DNSTAT5B are
strikingly different from those of DNP85, indicating dis-link between Bcl-2 and PI-3K has yet to be verified.
Several observations make it unlikely that triggering tinct roles of these two pathways in T cell development.
In contrast to DNP85, DNSTAT5B increases cell expan-the PI-3K/PKB pathway is the only function of the IL-
7Ra in T cell development. Most importantly, the effect sion in the FTOC. However, we also noted a dramatic
change in distribution of various subsets in the culturesof anti-IL-7Ra antibody is much stronger than that of
DNP85. While CD341 thymocytes expressing DNP85 with DNSTAT5B. The percentages of CD42CD82 DN and
of CD1a2 cells strongly increased and the percentagesgenerate close to normal ratios of TCRab and gd cells
(Figure 6), almost no TCRab were found in cultures with of DP and TCRab1 cells decreased upon expression of
DN STAT5B. It was furthermore observed that DNSTAT5Banti-IL-7Ra. TCRgd cell development was inhibited by
anti-IL-7Ra but to a lesser extent than TCRab develop- expanded TCRgd and NK cells.
One interpretation of these data is that DNSTAT5Bment (Figure 1). In addition, the cells incubated with
anti-IL-7Ra generated few DP cells while in the cultures confers a growth advantage to early progenitor cells
and thereby expands also the number of progeny thatwith DNP85 almost normal proportions of DP cells were
present. Furthermore, our data with the chimeric recep- are not dependent on STAT5B. This hypothesis would
imply that development of TCRgd and NK cells is not attor system seem to indicate that the Y449 mutation gives
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Japan; Ogihara et al., 1997) and dominant-negative STAT5B (giftall or is only slightly dependent on the activated STAT5B.
from Dr. Gouilleux; Moriggl et al., 1996) were subcloned in the LZRSIt is in this respect of note that development of TCRgd
vector. As a control, the IRES-e-GFP LZRS (C-GFP) vector wascells in our system is less sensitive to anti-IL-7Ra
used. Helper free recombinant virus was produced after transfection
blocking than TCRab development and that develop- into a 293T-based amphotrophic retroviral packaging cell line, Phoe-
ment of NK cells can proceed in the presence of anti-IL- nix (Kinsella and Nolan, 1996).
7Ra (Figure 1). The observation that TCRgd development
CTLL2 Cellsmay be less sensitive to inhibition by anti-IL-7Ra is sur-
Murine CTLL2 T cells express the IL-2R and IL-4R. They are IL-2prising since studies with IL-7- and IL-7R-deficient mice
dependent for survival and proliferation. They were maintained inhave shown that development of these cells is more
RPMI medium supplemented with 5% fetal calf serum (FCS), 5 3stringently dependent on IL-7 than that of TCRab1 T
1025 M b-mercaptoethanol, and 50 IU/ml recombinant human IL-2
cells (He and Malek, 1996; Maki et al., 1996). Whether (Chiron, The Netherlands). CTLL2 cells were transduced overnight
this reflects a difference between human and mouse or by C-GFP or WT IL-4R/IL-7R-GFP (WT) or Y449F IL-4R/IL-7R-GFP
(Y449F) viruses preincubated with 10 mg/ml DOTAP according to theis an artifact of the FTOC system has yet to be deter-
manufacturer's instructions (Boehringer Mannheim GmbH, Mann-mined. Development of NK cells is dependent not on
heim, Germany). Cells were subsequently sorted for their GFP ex-IL-7 but on IL-15 (Lodolce et al., 1998), and it is possible
pression and subcloned.that early development of NK cells does not involve
Cells were arrested in a quiescent state by washing three times
STAT5B activation. Another possible explanation for our in FCS and IL-2 free medium and replacing in RPMI medium supple-
findings is that expression of DNSTAT5B relieves a block mented with 0.5% FCS, 20 ng/ml transferrin, 0.4% bovine serum
albumin (BSA), and 30 nM selene in the absence of cytokine for 20on expansion of NK cells and TCRgd cells. It has to
hr. Cells were induced in the presence of hIL-2 or hIL-4 (kindlybe noted that STAT5B-deficient mice have a defect in
provided by R. de Waal Malefyt, DNAX Research Institute) for 10mature NK cells (Imada et al., 1998). However, that does
min at 378C. By incubating WT cells with either hIL-4 or mIL-4, wenot necessarily mean that early development of NK cells
confirmed that there was no cross-reactivity between hIL-4 and the
is affected by STAT5B deficiency. mIL-4R (data not shown).
The finding that DNSTAT5B stimulates expansion of
progenitors in our system is not consistent with observa- Isolation and Transduction of CD341 Cells
Human thymocytes were obtained from thymus fragments removedtions in the mouse. STAT5B-deficient mice have a some-
during corrective cardiac surgery of patients aged 1 month to 2what reduced cellularity of the thymus (Imada et al.,
years. Single cell suspensions of thymocytes and purified subsets1998), but STAT5A2/2 mice (Nakajima et al., 1997) and
were prepared as described previously (Res et al., 1996).
newborn STAT5A/B double deficient mice (Teglund et Highly purified CD341 thymocytes were cultured overnight in the
al., 1998) have a normal-sized thymus. It is possible that presence of 10 ng/ml IL-7 (R & D Systems, Abindon, UK) and 10
the STAT5 requirement for T cell development in human ng/ml SCF (R & D) followed by incubation for 7±8 hr or overnight
with virus supernatant in plates coated with 30 mg/ml recombinantand mouse is different. Another explanation for our ob-
human fibronectin fragment CH-296 (RetroNectin; Takara, Otsu, Ja-servations is that the effect of DNSTAT5B on cell expan-
pan) (Hanenberg et al., 1996, 1997).sion in our FTOC system is a consequence of a gain of
function. It is of note that natural STAT5 isoforms lacking
Proliferation Test
a transactivating domain, denoted STAT5b, have been Starved cells (5000/well) were incubated in normal culture medium
found to be expressed in hematopoietic cells (Wang et (150 ml) with the indicated concentration of hIL-2 or hIL-4 (0 to 50
al., 1996; Azam et al., 1997). The function of these iso- ng/ml) during 3 days. Cells were incubated with 0.5 mCi of thymidine/
well during 6±8 hr and harvested according to the manufacturer'sforms is yet unknown, but it is possible that the truncated
instructions (Packard Filter Mate).STAT5b forms interact with certain transcription factors
in analogy with the truncated STAT3b form (Schaefer et
Western Blotal., 1995). Regardless of the question of what the mech-
Partially or highly purified CD341 were starved for a few hours at
anism is of enhanced expansion of TCRgd and NK cells 48C in RPMI medium supplemented with 10% FCS before being
in FTOC cultures with DNSTAT5B-transduced progeni- induced in the presence of hIL-7 or hSCF (R & D Abingdon, UK) for
tor cells, our data taken together suggest that both the 10 min at 378C. Induction of the CD341 or of the CTLL2 cells was
stopped by washing them in ice-cold PBS. Cells were lysed for 30PI-3K/PKB and STAT5 pathways are involved in IL-7-
min at 48C in a 1% Triton buffer containing 10% glycerol, 100 mMdependent T cell differentiation in human, whereby PI-
NaCl, and 50 mM Tris (pH 7.5) and supplemented with 1 mM sodium-3K is important for cell survival of developing T cells.
orthovanadate, 1 mM phenylmethyl-sulfonide, 10 mg/ml leupeptine,
The function of STAT5 is different from that of the PI- 10 mg/ml pepstatine, and 10 mg/ml aprotinine. Extracts were cleared
3K/PKB pathway and may be necessary for an as yet by centrifugation at 14,000 g for 15 min at 48C. Proteins (2 3 106
undefined differentiation step marked by upregulation equivalent cells) were resolved by 8% SDS-PAGE and electrotrans-
ferred to nitrocellulose (Protran, Schleicher, and Schuell, USA).of CD1a, CD4, and CD8. The inactivation of the PI-3K/
Equivalent loading of the gel was checked by Ponceau red staining.PKB and STAT5 pathways combined may be responsi-
Membranes were blocked for 2 hr at room temperature with 3%ble for the effect of anti-IL-7R in our FTOC system.
bovine serum albumin (BSA) in PBS including 0.1% Tween20 (PBST)
and incubated overnight at 48C with the appropriate concentration
of specific antibodies in PBST. After washing, blots were incubatedExperimental Procedures
with horseradish peroxydase-conjugated second antibody and de-
veloped using an ECL system (Amersham, UK) according to theRetroviral Vectors and Production of Virus
manufacturer's instructions.We previously described a bicistronic LZRS vector containing the
gene of interest linked to a downstream internal ribosomal entry site
(IRES) sequence fused to a marker gene encoding for the enhanced Electrophoretic Mobility Shift Assays
Nuclear extracts were prepared as described (Pallard et al., 1995).green fluorescent protein (e-GFP) (Heemskerk et al., 1997). The
cDNA of the WT IL-4/IL-7R, the Y449F IL-4R/IL-7R (Corcoran et al., The oligonucleotide sequences used were derived from FcgR1 gene
promoter (GAS, 59-GATCGGGAAAGGGAAACCGAAACTGAACC-39).1996), and of a dominant-negative form of p85 (gift from Dr. Asano,
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The probe was end-labeled with (g-32P)ATP. Equal amounts of nu- and Spits, H. (1999). TCR gene rearrangements and expression of
the pre-T cell receptor complex during T cell differentiation. Bloodclear extract proteins (1 3 105 equivalent cells) were mixed with
40,000 c.p.m. of DNA probe, 5 mg Poly(dI)(dC) (Pharmacia), in a final 93, 3033±3043.
volume of 20 ml containing 20 mM Tris-Hcl (pH 7.9), 50 mM NaCl, Brennan, P., Babbage, J.W., Burgering, B.M., Groner, B., Reif, K.,
1 mM EDTA, 5% (v/v) glycerol, 5 mM dithiothreitol, 5 mM MgCl2, 1 and Cantrell, D.A. (1997). Phosphatidylinositol 3-kinase couples the
mg salmon sperm DNA, and 1 mM spermidine. When used, antibod- interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7,
ies (see below) were added to the nuclear extract in 20 mM Tris- 679±689.
HCL (pH 7.9), 50 mM NaCl, and 5% (v/v) glycerol and preincubated Burgering, B.M., and Coffer, P.J. (1995). Protein kinase B (c-Akt) in
for 30 min at 08C before adding the labeled probe, 1 mM EDTA, 5 phosphatidylinositol-3-OH kinase signal transduction. Nature 376,
mM dithiothreitol, 5 mM MgCl2, and 1 mg salmon sperm. After 25 599±602.
min at 258C, electrophoresis was carried out in 5% acrylamide/
Corcoran, A.E., Smart, F.M., Cowling, R.J., Crompton, T., Owen,bisacrylamide (38:2) gels in 0.53 Tris-borate EDTA for 3 hr at 180
M.J., and Venkitaraman, A.R. (1996). The interleukin-7 receptor aV. Gels were dried and subjected to autoradiography.
chain transmits distinct signals for proliferation and differentiation
during B lymphopoiesis. EMBO J. 15, 1924±1932.Fetal Thymic Organ Cultures
Dadi, H.K., and Roifman, C.M. (1993). Activation of phosphatidylino-In vitro development of human T and NK cells from CD341 thymo-
sitol-3 kinase by ligation of the interleukin-7 receptor on humancytes was studied in a hybrid human/mouse FTOC using fetal thymi
thymocytes. J. Clin. Invest. 92, 1559±1563.from 15 day embryos of RAG-1-deficient mice as described (Res et
al., 1996). 30 ng/ml hIL-4 was added twice a week while 50 mg/ml Del Peso, L.M., Gonzalez-Garcia, M., Page, C., Herrera, R., and
of a monoclonal antibody directed against the IL-7Ra was added Nunez, G. (1997). Interleukin-3-induced phosphorylation of BAD
once a week (CDW127, kindly provided by S. Saeland, Schering through the protein kinase Akt. Science 278, 687±689.
Plough France, Dardilly, France) (Pandrau-Garcia et al., 1994). DiSanto, J.P., Muller, W., Guy, G.D., Fischer, A., and Rajewsky, K.
(1995). Lymphoid development in mice with a targeted deletion of
Culture of CD341 Thymocytes in IL-7 the interleukin 2 receptor g chain. Proc. Natl. Acad. Sci. USA 92,
Purified CD341CD1a2 cells were transduced with either DNSTAT5B 377±381.
or with the control vector and cultured in Yssel's medium with 1%
Durum, S.K., Candeias, S., Nakajima, H., Leonard, W.J., Baird, A.M.,
pooled human serum with a combination of 10 ng/ml SCF and 10
Berg, L.J., and Muegge, K. (1998). Interleukin 7 receptor control of
ng/ml IL-7. The cultures were incubated in 96-well tissue culture
T cell receptor g gene rearrangement: role of receptor-associated
trays (Costar, Badhoevedorp, Netherlands).
chains and locus accessibility. J. Exp. Med. 188, 2233±2241.
Hanenberg, H., Xiao, X.L., Dilloo, D., Hashino, K., Kato, I., and Wil-Antibodies
liams, D.A. (1996). Colocalization of retrovirus and target cells onFor Western blotting, polyclonal antibodies directed against either
specific fibronectin fragments increases genetic transduction oftyrosine-phosphorylated STAT5 (kindly provided by New England
mammalian cells. Nat. Med. 2, 876±882.Biolabs) or serine 473-phosphorylated PKB (New England Biolabs)
Hanenberg, H., Hashino, K., Konishi, H., Hock, R.A., Kato, I., andwere used.
Williams, D.A. (1997). Optimization of fibronectin-assisted retroviral
gene transfer into human CD341 hematopoietic cells. Hum. GeneFACS Analysis and Antibodies Used
Ther. 8, 2193±2206.Cell suspensions were stained with the following TriColor (TRC)-
and PE-labeled antibodies and analyzed on a FACScan: CD8-TRC, He, Y.W., and Malek, T.R. (1996). Interleukin-7 receptor a is essential
CD3-TRC, and gd-TRC (all from Immunotech, Luminy, France), CD4- for the development of gd1 T cells, but not natural killer cells. J.
PE, CD56-PE (both from Becton Dickinson), and ab-PE (Immu- Exp. Med. 184, 289±293.
notech). Heemskerk, M.H.M., Blom, B., Nolan, G., Stegmann, A.P.A., Bakker,
A.Q., Weijer, K., Res, P.C.M., and Spits, H. (1997). Inhibition of T
Acknowledgments cell and promotion of natural killer cell development by the dominant
negative helix loop helix factor Id3. J. Exp. Med. 186, 1597±1602.
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